Elevance Health, Inc. — Director's Dealing 2013

Mar 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WELLPOINT, INC (WLP)
CIK: 0001156039
Period of Report: 2013-03-01

Reporting Person: NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-01	Common Stock	A	5995	—	Acquired	106111.51	Direct
2013-03-01	Common Stock	A	7273	—	Acquired	113384.51	Direct
2013-03-01	Common Stock	F	1922	$61.88	Disposed	111462.51	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-01	Stock Option (Right to Buy)	$61.88	A	20904	Acquired	2020-03-01	Common Stock (20904)	Direct

Footnotes

F1: Represents performance based restricted share units. Restrictions lapse as follows: 2,997 on 3/1/14 and 2,998 on 3/1/15.

F2: Represents restricted share units. Restrictions lapse as follows: 2,424 each on 3/1/14 and 3/1/15, and 2,425 on 3/1/16.

F3: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

F4: Exercisable in six installments of 3,484 each on 9/1/13, 3/1/14, 9/1/14, 3/1/15, 9/1/15 and 3/1/16.